Published in Diabetes Care on May 01, 1996
The global impact of non-communicable diseases on healthcare spending and national income: a systematic review. Eur J Epidemiol (2015) 1.06
A comparative study of two various models of organising diabetes follow-up in public primary health care - the model influences the use of services, their quality and costs. BMC Health Serv Res (2014) 0.90
Costs, outcomes and challenges for diabetes care in Spain. Global Health (2013) 0.88
Inpatient care of patients with type 1 diabetes mellitus by duration of diabetes and sex: A nationwide population-based longitudinal study. Risk Manag Healthc Policy (2009) 0.78
Contacting dropouts from type 2 diabetes care in public primary health care: description of the patient population. Scand J Prim Health Care (2016) 0.75
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med (2001) 56.11
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med (1998) 25.66
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet (2006) 15.32
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet (2005) 13.18
Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet (2001) 10.29
A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet (1998) 8.02
Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J (1991) 6.35
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J (2005) 5.40
Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia (1992) 5.25
Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol (1996) 3.77
Smoking and risk of rheumatoid arthritis. J Rheumatol (1993) 3.63
Flavonoid intake and coronary mortality in Finland: a cohort study. BMJ (1996) 3.56
Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther (2007) 3.53
The fetal and childhood growth of persons who develop type 2 diabetes. Ann Intern Med (2000) 3.10
Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev (1987) 2.88
NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes (1994) 2.67
Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland. Study design and 1-year interim report on the feasibility of the lifestyle intervention programme. Diabetologia (1999) 2.51
Prevalence of age-associated memory impairment in a randomly selected population from eastern Finland. Neurology (1995) 2.44
Incidence of cardiovascular disease in Type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland. Diabetologia (1998) 2.25
Social alcohol consumption and low Lp(a) lipoprotein concentrations in middle aged Finnish men: population based study. BMJ (1998) 2.16
Is skin preparation necessary before insulin injection? Lancet (1978) 2.15
Food consumption and the incidence of type II diabetes mellitus. Eur J Clin Nutr (2005) 2.14
Ten year mortality and causes of death in patients with rheumatoid arthritis. Br Med J (Clin Res Ed) (1985) 2.10
Determinants of weight gain and overweight in adult Finns. Eur J Clin Nutr (1991) 2.04
Apolipoprotein E phenotype determines the effect of alcohol on blood pressure in middle-aged men. Am J Hypertens (1998) 2.02
Prevalence and prognostic significance of short QT interval in a middle-aged Finnish population. Circulation (2007) 1.98
Hyperinsulinemia predicts coronary heart disease risk in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Circulation (1998) 1.98
Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1. J Clin Invest (2000) 1.97
Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke (1996) 1.97
Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion. Diabetologia (2007) 1.97
Alterations in insulin absorption and in blood glucose control associated with varying insulin injection sites in diabetic patients. Ann Intern Med (1980) 1.96
Poor glycemic control predicts coronary heart disease events in patients with type 1 diabetes without nephropathy. Arterioscler Thromb Vasc Biol (1999) 1.95
Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland. Am J Hum Genet (2000) 1.93
Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke (1998) 1.88
Natural course of insulin resistance in type I diabetes. N Engl J Med (1986) 1.82
Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol (1994) 1.82
Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland. Eur Heart J (1996) 1.82
Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma. Finnish Leukaemia Group. Lancet (1992) 1.80
Risk factors predicting lower extremity amputations in patients with NIDDM. Diabetes Care (1996) 1.78
Coffee consumption, rheumatoid factor, and the risk of rheumatoid arthritis. Ann Rheum Dis (2000) 1.74
Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance. Diabetologia (2010) 1.64
Insulin resistance syndrome predicts coronary heart disease events in elderly nondiabetic men. Circulation (1999) 1.64
Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes (1997) 1.64
Malignancies in cases with screening-identified evidence of coeliac disease: a long-term population-based cohort study. Gut (2008) 1.64
Synergistic effect of polymorphisms in uncoupling protein 1 and beta3-adrenergic receptor genes on basal metabolic rate in obese Finns. Diabetologia (1998) 1.63
Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol (2000) 1.62
European stroke prevention study: effectiveness of antiplatelet therapy in diabetic patients in secondary prevention of stroke. Stroke (1992) 1.59
The Social Insurance Institution's coronary heart disease study. Baseline data and 5-year mortality experience. Acta Med Scand Suppl (1983) 1.59
Hyperglycemia decreases glucose uptake in type I diabetes. Diabetes (1987) 1.58
Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data. Diabetologia (2004) 1.57
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia (2012) 1.55
Variation at the cholesteryl ester transfer protein gene in relation to plasma high density lipoproteins cholesterol levels and carotid intima-media thickness. Eur J Clin Invest (2001) 1.54
The common SLC30A8 Arg325Trp variant is associated with reduced first-phase insulin release in 846 non-diabetic offspring of type 2 diabetes patients--the EUGENE2 study. Diabetologia (2008) 1.53
Insulin action and age. European Group for the Study of Insulin Resistance (EGIR). Diabetes (1996) 1.52
Dietary manipulation of beta cell autoimmunity in infants at increased risk of type 1 diabetes: a pilot study. Diabetologia (2005) 1.52
Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23. Nat Genet (1998) 1.52
Hyperhomocystinemia: a risk factor or a consequence of coronary heart disease? Arch Intern Med (2001) 1.50
Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up study. Diabetologia (2007) 1.50
Physiological importance of dehydroepiandrosterone. Lancet (1994) 1.49
Low levels of sex hormone-binding globulin and testosterone are associated with smaller, denser low density lipoprotein in normoglycemic men. J Clin Endocrinol Metab (1996) 1.49
Leptin concentrations, sex hormones, and cortisol in nondiabetic men. J Clin Endocrinol Metab (1997) 1.49
Association of angiotensin converting enzyme and plasminogen activator inhibitor-1 promoter gene polymorphisms with features of the insulin resistance syndrome in patients with premature coronary heart disease. Atherosclerosis (2001) 1.49
Oxidised LDL and progression of atherosclerosis. Lancet (1992) 1.49
Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men. Arterioscler Thromb Vasc Biol (2001) 1.48
Localization of rate-limiting defect for glucose disposal in skeletal muscle of insulin-resistant type I diabetic patients. Diabetes (1990) 1.47
Impairment of diastolic function in middle-aged type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients free of cardiovascular disease. Diabetologia (1988) 1.46
Association of metabolic syndrome with Alzheimer disease: a population-based study. Neurology (2006) 1.45
Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia. Hum Gene Ther (1998) 1.45
Risk factors for injurious falls leading to hospitalization or death in a cohort of 19,500 adults. Am J Epidemiol (1993) 1.43
Validity of hospital discharge data in a prospective epidemiological study on stroke and myocardial infarction. Acta Med Scand (1984) 1.43
Quality of life and functional ability in hip and knee replacements: a prospective study. Qual Life Res (1996) 1.42
Is there a sex difference in the association of plasma insulin level and insulin sensitivity with serum lipids and lipoproteins? Metabolism (1994) 1.42
Cognitive load and detection thresholds in car following situations: safety implications for using mobile (cellular) telephones while driving. Accid Anal Prev (1999) 1.40
Insulin analogues and their potential in the management of diabetes mellitus. Diabetologia (1999) 1.40
Guar gum in insulin-dependent diabetes: effects on glycemic control and serum lipoproteins. Am J Clin Nutr (1992) 1.40
Cognitive function in an elderly population with persistent impaired glucose tolerance. Diabetes Care (1998) 1.39
Association of the PRO12ALA polymorphism of the PPAR-gamma2 gene with oxidized low-density lipoprotein and cardiolipin autoantibodies in nondiabetic and type 2 diabetic subjects. Metabolism (2003) 1.38
Health and quality of life before and after hip or knee arthroplasty. J Arthroplasty (1995) 1.38
Serum cholesterol and risk of cancer in a cohort of 39,000 men and women. J Clin Epidemiol (1988) 1.38
Independent influence of age on basal insulin secretion in nondiabetic humans. European Group for the Study of Insulin Resistance. J Clin Endocrinol Metab (1999) 1.37
Physical training and insulin sensitivity. Diabetes Metab Rev (1986) 1.37
The epidemiology of insulin-dependent diabetes mellitus (IDDM) in Finland and in northern Europe. Diabetes Care (1985) 1.36
Common candidate gene variants are associated with QT interval duration in the general population. J Intern Med (2009) 1.35
Prevalence and ten-year (1970-1979) incidence of insulin-dependent diabetes mellitus in children and adolescents in Finland. Acta Paediatr Scand (1982) 1.34
Hyperuricemia as a risk factor for cardiovascular mortality. Acta Med Scand Suppl (1982) 1.34
Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial. Diabetologia (2004) 1.33
Increased insulin sensitivity and insulin binding to monocytes after physical training. N Engl J Med (1979) 1.33
Verbal fluency activates the left medial temporal lobe: a functional magnetic resonance imaging study. Ann Neurol (2000) 1.32
Evidence of a state of increased insulin resistance in preeclampsia. Metabolism (1999) 1.31
Body iron stores and risk of cancer. Int J Cancer (1994) 1.31
Alcohol consumption and sudden coronary death in middle-aged Finnish men. Acta Med Scand (1987) 1.31
Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest (1992) 1.30
Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment. Multicenter Insulin Lispro Study Group. Diabetes (1997) 1.30
Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects. Stroke (1996) 1.29
Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J Intern Med (1999) 1.27
Effects of leg exercise on insulin absorption in diabetic patients. N Engl J Med (1978) 1.27
Prevalence of retinopathy in people with diabetes, impaired glucose tolerance, and normal glucose tolerance. Diabetes Care (1998) 1.26
Rheumatoid factor, chronic arthritis and mortality. Ann Rheum Dis (1995) 1.26
Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia (1993) 1.26